Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had actually fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Performance - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, significantly below analysts' expectations. The company also projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - Grabar Law Office is investigating claims against Integer Holdings, Corp. regarding potential breaches of fiduciary duties by certain officers and directors [1][3]. Group 1: Investigation Details - The investigation focuses on whether officers and directors of Integer Holdings, Corp. breached their fiduciary duties to the company [1]. - Shareholders who purchased shares prior to July 25, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2][4]. Group 2: Allegations of Misconduct - A federal securities fraud class action complaint alleges that Integer Holdings made materially false and misleading statements about its business and operations [3]. - Specific allegations include: 1. Integer overstated its competitive position in the EP manufacturing market [3]. 2. The company experienced a deterioration in sales for two of its EP devices, contrary to claims of strong customer demand [3]. 3. Integer mischaracterized its EP devices as long-term growth drivers for its C&V segment [3]. 4. Positive statements made by the defendants about the company's prospects were materially false and lacked a reasonable basis [3].

SAN FRANCISCO--(BUSINESS WIRE)--National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against CarMax, Inc. (NYSE: KMX) – January 2, 2026 – is rapidly approaching. The lawsuit alleges that CarMax and certain of its executives misled investors about the true stability and growth prospects of its core business, leading to two separate and massive stock crashes. Hagens Berman urges investors who suffered substantial. ...

Core Viewpoint - A class action lawsuit has been filed against Citadel Securities LLC and Virtu Americas LLC on behalf of investors who sold Genius Group Limited securities during the specified class period, alleging manipulative trading practices that artificially deflated the stock price [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for alleged violations of federal securities laws for all individuals and entities that sold Genius securities between April 12, 2022, and May 30, 2025 [2]. - The Complaint alleges that the Defendants engaged in manipulative trading practices, including a scheme known as "spoofing," which involved placing and canceling buy or sell orders without genuine intent [3][8]. - Defendants allegedly misled market participants about supply, demand, and volatility for Genius securities, creating a false impression of market dynamics [8]. Group 2: Legal Representation - Bronstein, Gewirtz & Grossman LLC represents investors on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful [4]. - The firm has a track record of recovering hundreds of millions of dollars for investors in securities fraud class actions and emphasizes restoring investor capital and ensuring corporate accountability [5].

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Ltd. and certain officers for alleged violations of federal securities laws during the Class Period from April 21, 2023, to April 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Jayud securities during the specified Class Period [2]. - The Complaint alleges that Defendants made materially false and misleading statements and failed to disclose adverse facts about the Company's business and operations [3]. - Specific allegations include involvement in a fraudulent stock promotion scheme, use of offshore accounts for share dumping, omission of false rumors affecting stock price, and misleading positive statements about the Company's prospects [3]. Group 2: Next Steps for Investors - Investors wishing to join the lawsuit can review the Complaint on the law firm's website and must request to be appointed as lead plaintiff by January 19, 2026 [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [5]. - The firm has a strong track record, having recovered hundreds of millions of dollars for investors in securities fraud cases [6].

Core Viewpoint - Klarna Group plc is under investigation for potential violations of federal securities laws following disappointing financial results after its IPO, which may contradict prior assurances regarding lending risk metrics [1][2]. Group 1: Company Overview - Klarna provides payment, advertising, and digital retail banking solutions to consumers and merchants [2]. - The company conducted its IPO at a price of $40.00 per share on September 10, 2025 [2]. Group 2: Financial Performance - Klarna's third quarter 2025 financial results, released on November 18, 2025, revealed a significant increase in the company's provision for credit losses, raising concerns among investors [2]. - Following the earnings report, Klarna's stock price dropped by $3.25 per share, approximately 9.3%, closing at $31.63 on November 18, 2025, down from $34.88 the previous day [3]. - Since its IPO, Klarna's stock has declined over 23%, falling to approximately $30.80 by December 4, 2025 [3].

Core Viewpoint - Rezolute, Inc. experienced a significant decline in share price, falling over 85% after the failure of its Phase 3 sunRIZE study in congenital hyperinsulinism, which did not meet its primary or key secondary endpoints. This has raised concerns about potential securities law violations due to misleading statements made by the company regarding earlier data and program outlook [2]. Group 1: Company Performance - Shares of Rezolute, Inc. fell over 85% on December 11, 2025, following the announcement of the failed Phase 3 study [2]. - The company had previously made optimistic statements about the strength of earlier data, which may have misled investors [2]. Group 2: Legal Investigation - Block & Leviton is investigating Rezolute, Inc. for potential securities law violations and may file an action to recover losses for affected investors [4]. - Investors who have lost money in their Rezolute, Inc. investment are encouraged to contact Block & Leviton for more information on recovery options [1][5]. Group 3: Investor Eligibility - Any individual who purchased common stock of Rezolute, Inc. and has seen a decline in their shares may be eligible for recovery, regardless of whether they have sold their investment [3]. Group 4: Whistleblower Information - Individuals with non-public information about Rezolute, Inc. are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, which offers rewards of up to 30% of any successful recovery [6]. Group 5: Firm Reputation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Core Viewpoint - A class action lawsuit has been filed against Sprouts Farmers Market, Inc. for alleged securities fraud and unlawful business practices following disappointing financial results and lowered guidance [2][3]. Financial Performance - On October 29, 2025, Sprouts reported disappointing third-quarter results for fiscal 2025, with comparable store growth falling below expectations [3]. - The company also provided disappointing guidance for the fourth quarter and reduced its full-year estimates, despite having raised them just one quarter prior [3]. - The decline in performance was attributed to "challenging year-on-year comparisons" and indications of a softening consumer [3]. - Following the announcement, Sprouts' stock price dropped by $27.30 per share, or 26.11%, closing at $77.25 per share on October 30, 2025 [3]. Legal Action - Investors who purchased Sprouts securities during the class period have until January 26, 2026, to request to be appointed as Lead Plaintiff in the class action [2]. - The lawsuit raises concerns about potential securities fraud and other unlawful business practices by Sprouts and its officers and/or directors [2].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Caledonia Mining Corporation Plc and its officers or directors [1] Group 1: Company Overview - Caledonia Mining Corporation Plc is listed on the NYSE under the ticker CMCL [1] - The company operates the Blanket Mine in Zimbabwe, which is affected by proposed changes to the gold mining royalty and tax regimes [2] Group 2: Financial Impact - On December 1, 2025, Caledonia disclosed that the proposed changes could reduce profitability and cash flow at the Blanket Mine, potentially falling short of market expectations [2] - Following this announcement, Caledonia Mining's stock price dropped by $4.44 per share, or 14.41%, closing at $26.37 per share [2] Group 3: Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [3]

Core Viewpoint - A class action lawsuit has been filed against Blue Owl Capital Inc. for alleged securities fraud and unlawful business practices, with investors encouraged to join the lawsuit [1][2]. Financial Performance - Blue Owl reported fee-related earnings of $376.2 million for Q3 2025, missing consensus estimates, with fee-related earnings margins at 57.1%, falling short by approximately 20 basis points [3]. - Performance revenue declined by 33% year-over-year, amounting to only $188,000 [3]. Stock Price Movements - Following the Q3 earnings report, Blue Owl's stock price dropped by $0.70, or 4.23%, closing at $15.86 on October 30, 2025 [4]. - After the announcement of a merger agreement between Blue Owl Capital Corporation and Blue Owl Capital Corporation II, the stock price fell by $0.74, or 4.72%, to close at $14.95 on November 6, 2025 [4]. - A subsequent article from The Financial Times indicated potential losses for investors in connection with the merger, leading to a further decline in stock price by $0.85, or 5.8%, closing at $13.77 on November 17, 2025 [5]. - On November 19, 2025, Blue Owl announced the termination of the proposed merger due to current market conditions [6].